Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00432536 · ClinicalTrials.gov registry record
Redesigning Cardiac Surgery to Reduce Neurologic Injury
A clinical trial of Cardiovascular Disease and Surgery, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- 469
- Enrollment target
- 3
- Study locations
NCT00432536: Completed study of Cardiovascular Disease and Surgery, sponsored by Dartmouth-Hitchcock Medical Center.
NCT00432536 is a study of Cardiovascular Disease and Surgery that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 469 participants, below the 2,694-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (83% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00432536, a study of Cardiovascular Disease and Surgery, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- 469 participants
- Enrollment target
- 3
- Study locations
Study Summary
Neurologic injuries are frequent and devastating complications following cardiac surgery. Previous work conducted by our research group and others has identified the principal mechanisms creating both overt and subtle neurologic injuries after cardiac surgery. Current work by our group has identified that the causes (thrombotic/lipid emboli, cerebral hypoperfusion \& hypotension, and gaseous emboli) of these injuries are byproducts of processes of surgical and perfusion care. This insight suggests that the redesign of clinical strategies and techniques to prevent the occurrence of these intraoperative sources of damage may provide an opportunity to reduce the risk of neurologic injury after cardiac surgery. The goal of this research is to identify modifiable clinical strategies and techniques of surgical and perfusion care associated with the causes (thrombotic/lipid emboli, cerebral hypoperfusion \& hypotension, and gaseous emboli) of neurologic injury secondary to coronary artery bypass graft (CABG) surgery, and subsequently to redesign these processes to reduce a patient's risk of a neurologic injury.
Primary Outcome
We will count the number of thrombotic/lipid emboli and number of gaseous emboli. Along with the number of hypotensive events. We will link counts to surgical and perfusion techniques.
Conditions Studied
Interventions
- OTHER Quality improvement intervention
Study Locations (3)
New Hampshire
- Dartmouth-Hitchcock Medical Center - Lebanon
- Catholic Medical Center - Manchester
Maine
- Maine Medical Center - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 469 participants |
| Start Date | 2002-10 |
| Est. Completion | 2012-02 |
What the finished NCT00432536 record still lists
NCT00432536 is an observational study that tracks outcomes without assigning an intervention. The registered 469 participants enrollment target is mid-sized for trials with a published cap, below the 2,694-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (83% lower).
The record links to 2 conditions, with Cardiovascular Disease appearing as the primary indexed condition, and to 1 intervention - of which Quality improvement intervention is the first listed.
NCT00432536 reports a single indexed study location in New Hampshire, Maine.
Frequently Asked Questions
What is clinical trial NCT00432536 about?
NCT00432536 is a clinical study titled "Redesigning Cardiac Surgery to Reduce Neurologic Injury". Neurologic injuries are frequent and devastating complications following cardiac surgery. Previous work conducted by our research group and others has identified the principal mechanisms creating both overt and subtle neurologic injuries after cardiac surgery. Current work by our group has identifie...
What is the current status of trial NCT00432536?
This trial is currently completed. The enrollment target is 469 participants. The study started on 2002-10. Estimated completion is 2012-02.
What conditions does trial NCT00432536 study?
This clinical trial studies the following conditions: Cardiovascular Disease, Surgery.
What interventions are being tested in trial NCT00432536?
The interventions under investigation include: Quality improvement intervention (OTHER).
Who is sponsoring clinical trial NCT00432536?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00432536 being conducted?
This trial has 3 study locations across Maine, New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00432536's enrollment target sits among peer trials
469 36th of 137 higher than 102 of 137 other Cardiovascular Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Single-tracer Multiparametric PET Imaging
RECRUITING · Early Phase 1
-
WISE CVD - Continuation (WISE HFpEF)
RECRUITING
-
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
RECRUITING · NA
-
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RECRUITING · Phase 3
-
Human Biospecimen Procurement Protocol: Biorepository to Support Translational Research to Identify Disease Mechanism(s)
RECRUITING
-
Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05256940 · 470 participants · NA
Motivational Interviewing to Address Suicidal Ideation for Veterans at High Risk for Suicide
- NCT05458219 · 470 participants · Phase 1
A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
- NCT05850689 · 470 participants · Phase 3
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- NCT05935384 · 470 participants
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia